INTEGRATED BIOPHARMA INC - FORM 10-Q - EX-32.1 - EXHIBIT 32.1 CERITICATION OF PERIODIC REPORT PURSUANT TO SECTION 302 CO-CEOS - May 13, 2020

Attached files

file filename
10-Q - FORM 10-Q - INTEGRATED BIOPHARMA INCinbp20200331b_10q.htm
EX-32.2 - EXHIBIT 32.2 CERTIFICATION OF PERIODIC REPORT PURSUANT TO SECTION 301 CFO - INTEGRATED BIOPHARMA INCex_186201.htm
EX-31.2 - EXHIBIT 31.2 CERTIFICATION OF CFO - INTEGRATED BIOPHARMA INCex_186199.htm
EX-31.1 - EXHIBIT 31.1 CERTIFICATION OF CO-CEOS - INTEGRATED BIOPHARMA INCex_186198.htm
EX-10.1 - EXHIBIT 10.1 PAYROLL PROTECTION PROGRAM LOAN - INTEGRATED BIOPHARMA INCex_185003.htm

Exhibit 32.1

CERTIFICATION OF PERIODIC REPORT

As adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

 

In connection with the Quarterly Report on Form 10-Q for the second quarter ended March 31, 2020 of Integrated BioPharma, Inc. (the “Company”) as filed with the Securities and Exchange Commission on the date hereof (the “Report”), Christina Kay and Riva Sheppard, Co-Chief Executive Officers of Integrated BioPharma, Inc. certify, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, 18 U.S.C. Section 1350, that to their knowledge:

 

 

1.

the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 (15 U.S.C. 78m or 78o(d)); and

 

 

2.

the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

This certification accompanies the Report pursuant to Section 906 of Sarbanes-Oxley Act of 2002 and shall not, except to the extent required by the Sarbanes-Oxley Act of 2002, be deemed filed by the Company for purposes of Section 18 of the Securities Exchange Act of 1934, as amended.

 

A signed original of this written statement has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.

 

Dated:  May 13, 2020 By: /s/ Christina Kay                                
         Name: Christina Kay,
         Title:   Co-Chief Executive Officer
   
   By: /s/ Riva Sheppard                                
         Name: Riva Sheppard,
         Title:   Co-Chief Executive Officer

 

 

 

                                                                                   

 

 

 

 

 

 

 

                                                                                    

 

 

 

 

 

 

Stock widget

Investing forum

INTEGRATED BIOPHARMA INC Reports